Which statement about depression neurotransmitters is true?

Prepare for the PMHNP Certification Exam with targeted questions and expert explanations. Master the topics with insights into the exam format and key strategies to succeed.

Multiple Choice

Which statement about depression neurotransmitters is true?

Explanation:
Depression is tied to reduced activity of monoamine neurotransmitters in mood-regulating brain circuits. In many patients with major depressive disorder, levels of serotonin, norepinephrine, and dopamine are decreased, which helps explain symptoms like low mood, lack of energy, and anhedonia. This is why treatments that boost these transmitters—SSRIs raising serotonin, SNRIs raising serotonin and norepinephrine, bupropion increasing dopamine and norepinephrine, and MAO inhibitors preventing breakdown—are effective. While GABA and glutamate may also be involved in mood regulation, the classic pharmacologic understanding centers on decreased monoamines, making the statement about all three being decreased the best fit. The other options don’t align with this widely taught pattern.

Depression is tied to reduced activity of monoamine neurotransmitters in mood-regulating brain circuits. In many patients with major depressive disorder, levels of serotonin, norepinephrine, and dopamine are decreased, which helps explain symptoms like low mood, lack of energy, and anhedonia. This is why treatments that boost these transmitters—SSRIs raising serotonin, SNRIs raising serotonin and norepinephrine, bupropion increasing dopamine and norepinephrine, and MAO inhibitors preventing breakdown—are effective. While GABA and glutamate may also be involved in mood regulation, the classic pharmacologic understanding centers on decreased monoamines, making the statement about all three being decreased the best fit. The other options don’t align with this widely taught pattern.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy